Erinaco company was founded in 2016 in Moscow.
We are focused on the research and development of the new treatment approaches. Our priority is Pulmonology.
Russian companies produce “rescue medications” mainly, which used during the exacerbations period and in the hospitals and are not used for the maintenance treatment. Medicines for the pulmonary diseases maintenance treatment are produced by the foreign companies.
There is huge unmet need in the development and production of domestic, innovative and qualitative medicines for pulmonary diseases in Russia.
Our aim: Russian pharmaceutical market development.
Our main streams:
- New approaches for lung diseases treatment discovery
- New medicines research and development
- Drugs for lung diseases treatment registration and launch
- Russian pulmonology scientific potential development